Associated Papers
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression.
Tantawy SI et al.
Blood Cancer Journal, 2025
The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification.
Fanelli A et al.
Scientific Reports, 2024
39134766 (PubMed )
Supplement: 41598_2024_69716_MOESM7_ESM.xlsx › Foglio1
Unraveling the genetics of transformed splenic marginal zone lymphoma.
Grau M et al.
Blood Advances, 2023
36995085 (PubMed )
Supplement: BLOODA_ADV-2022-009415-mmc1.xlsx › ST7
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations.
Wu C et al.
Oncotarget, 2016
27224912 (PubMed )
Supplement: oncotarget-07-38180-s001.pdf
Select a paper to view details